The G protein-coupled estrogen receptor (GPER) is a significant modulator of arterial contractility and blood flow. The GPER-specific activator, G-1, has been widely used to characterize GPER function in a variety of tissue types. Large conductance, calcium (Ca 2+ )-activated K + (BK) channels are sensitive to 17b-estradiol (17b-E2) and estrogenic compounds (e.g., tamoxifen, ICI 182 780) that target estrogen receptors.
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) affinity for 17b-estradiol (17b-E2), GPER activation leads to a broad range of rapid physiological processes that include protein kinase activation (e.g., Erk-1, Erk-2, and PKA) and intracellular calcium ([Ca 2+ ] i ) mobilization. [2] [3] [4] In arteries, GPER activation induces vasodilation, which has been reported to involve the generation of cAMP and PKA activation and the activation of potassium (K + ) channels. [5] [6] [7] [8] [9] In arterial smooth muscle cells (myocytes), the classical nuclear ERs (ERa, ERb) along with GPER are expressed, 10 thus in the characterization of GPER it is important to utilize appropriate pharmacological treatments that specifically target the receptor. G-1 (1-[4-(6-bromobenzo [1, 3] dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c].
quinolin-8-yl]-ethanone) was introduced as a specific GPER agonist that exhibited a high affinity (~10 nmolÁL À1 ) for GPER with no appreciable affinity for ERa or ERb. 11 G-1 administration elicits vasodilation in many different artery types, 7 however, the maximum vasodilatory effect is less than what is achieved with 17b-E2. 12, 13 As such, a moderate vasodilatory response is commonly associated with GPER activation.
Large conductance, calcium (Ca 2+ )-activated K + (BK) channel activation is a putative downstream mechanism associated with GPER activation. 9 In cerebral arteries, BK channels are critical for the regulation of myocyte plasma membrane potential where channel activation leads to K + efflux, membrane hyperpolarization, and vasodilation. 14, 15 BK channel function is primarily regulated through Ca 2+ spark activity, Ca 2+ release events that occur via ryanodinesensitive Ca 2+ (RyR) channels at the sarcoplasmic reticulum. 16, 17 Ca 2+ sparks (~10-30 lmolÁL À1 ) can activate clusters of proximal BK channels on the plasma membrane, which lead to large, transient BK currents. 18, 19 BK channels are especially relevant to 17b-E2-mediated vasodilation as 17b-E2 can directly activate BK channels via an extracellular binding site on the regulatory b1 subunit. 20 Subsequent studies of the broad ER (a,b) inhibitor, ICI 182 780, and the selective estrogen receptor modulator, tamoxifen, have also demonstrated that BK channels can be directly modulated by estrogenic compounds leading to alterations in BK channel activation. 21, 22 In coronary arterial myocytes, G-1-mediated GPER activation increased BK channel activation leading to vasodilation, which was believed to be independent of direct interactions between G-1 and the BK channel. 9 However, this study did not utilize physiological conditions typically associated with BK channel activation. Given the history of ER-targeting compounds to possess direct effects on BK channel activation, it is important to further assess for direct effects of G-1 on BK channel function. Moreover, a careful study is warranted as much of the vasodilatory capacity attributed to GPER is primarily examined using G-1 as the means to activate the receptor. control experiments were performed to test for vehicle effects on single BK channel activity and patch/cell viability. For inside-out patch-clamp protocols, BK channel activity was allowed to stabilize for 2-3 minutes prior to adding G-1. G-1 was perfused into the bath using gravity flow followed by an additional 2-3 minutes of gap-free recording to detect a G-1 effect. For perforated whole-cell patchclamp protocols, recording began~10 minutes after obtaining a gigaohm seal to allow for perforation of the plasma membrane. Baseline transient BK currents were recorded for~5 minutes followed by administration of G-1 as described above. BK single-channel activity 
| MATERIALS AND METHODS
| Statistics
Data and statistical analysis comply with recommendations on experimental design and analysis in pharmacology. 24 Data are expressed as mean AE SE. Statistically significant differences between mean data were identified using a repeated measures analysis of variance (ANOVA). In our experiments, group sizes of 6-8 per group possess sufficient power (>0.80) to detect statistically significant mean differences at a = 0.05.
| Materials
All materials used in this manuscript were purchased from SigmaAldrich (St. Louis, MO, USA) with the following exceptions: G-1 (Cayman; Ann Arbor, MI, USA) and iberiotoxin (Bachem; Torrance, CA, USA).
| RESULTS
Inside-out patch clamp was performed on freshly isolated cerebral arterial myocytes to determine the effects of G-1 on BK channel activation. Membrane patches were voltage clamped at À40 mV and free Ca 2+ was maintained at 10 lmolÁL
À1
, parameters that fall within the physiological ranges of cerebral arterial myocytes. 
| DISCUSSION AND CONCLUSIONS
Here, we investigated the effects of G-1, the specific GPER agonist, on BK channel activation in cerebral arterial myocytes. Our EVANSON ET AL.
F I G U R E 2
Vehicle alone has no effect on BK channel activation in arterial myocytes. G-1 (activator) along with G15 and G36 (inhibitors) are chemicals that were designed to specifically target the GPER receptor without any effects on classical estrogen receptors (e.g., ERa, ERb). 11, 26, 27 In binding-affinity studies using recombinant expression of GPER, G-1 exhibited a comparable affinity for GPER as compared to 17b-E2 (G-1:
). 11 In this salient study, G-1 activated GPER, expressed at the endoplasmic reticulum GPER function underlies many of the rapid, nongenomic effects of estrogen. 1, 41 Moreover, estrogen receptor antagonists (e.g., fulvestrant) and selective estrogen receptor modulators (tamoxifen, raloxifene) are also capable of GPER activation. 35 Many of the aforementioned estrogens and estrogen-like drugs (fulvestrant, tamoxifen)
can also activate BK channels, leading to increased BK channel openings and currents. [20] [21] [22] It is particularly interesting that G-1, the only available specific GPER agonist, actually reduces BK channel activation, which in arteries would oppose GPER-mediated vasodilation. These data underscore the difficulty in targeting specific estrogen receptors without initiating off-target effects that could interfere with the desired response. It is also possible that the specific GPER inhibitors, G15 and G36, may also possess some degree of affinity for BK channel subunits as they share structural similarities to G-1. 26, 27 Future studies of GPER on vascular function would benefit from the development of new pharmacological tools to specifically target GPER without the off-target effects that involve proteins (e.g., BK channels) critical to the maintenance of myogenic tone.
In conclusion, G-1, the specific activator for GPER, directly inhibits BK channel activation in cerebral arterial myocytes. G-1 altered BK channel activation through elevated close times, which attenuated physiological BK currents in cerebral arterial myocytes. G-1 elicited vasodilation of endothelium-denuded pressurized cerebral arteries, which occurred despite a reduction in BK channel function.
Our data would suggest that GPER is potentially capable of eliciting a greater magnitude of vasodilation, and G-1 may potentially mask the full effect of GPER on arterial contractility. 
ACKNOWLEDGEMENTS
